Related Experiment Video
Updated: Jun 8, 2025

03:20
Author Spotlight: Exploring Non-Motor Symptoms in Parkinson's Disease
Published on: September 22, 2023
1.5K
Gut microbiota and Parkinson's disease
Lin Wang1, Ying Cui1, Bingyu Han1
1Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
Chinese Medical Journal
|November 6, 2024
Summary
Gut microbiota dysbiosis is linked to Parkinson's disease (PD) development. Alterations in the gut microbiome may influence PD progression, highlighting the importance of the microbiota-gut-brain axis in neurodegeneration.
Area of Science:
- Neuroscience
- Microbiology
- Gastroenterology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder with increasing prevalence.
- Emerging evidence implicates gut microbiota dysbiosis in PD pathogenesis.
- The microbiota-gut-brain axis is recognized as a key player in PD development and progression.
Purpose of the Study:
- To review the characterization of gut microbiota in PD patients.
- To explore associations between gut microbiota and clinical symptoms of PD.
- To highlight potential mechanisms linking gut microbiota to PD pathogenesis.
Main Methods:
- Literature review of studies investigating gut microbiota in Parkinson's disease.
- Analysis of associations between microbial composition and PD clinical features.
- Synthesis of current understanding regarding the microbiota-gut-brain axis in PD.
Main Results:
- Significant alterations in gut microbiota composition are observed in PD patients compared to healthy individuals.
- Specific microbial changes correlate with PD clinical symptoms and disease severity.
- The gut microbiota exerts a notable influence on the pathological processes of PD.
Conclusions:
- Gut microbiota dysbiosis is strongly associated with the pathogenesis of Parkinson's disease.
- Modulating the intestinal microbiota shows potential as a therapeutic strategy for PD.
- Further research is necessary to fully elucidate the specific mechanisms underlying the gut microbiota's role in PD.
Related Concept Videos
Parkinson's Disease: Treatment
224
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
224
Parkinson's Disease: Overview
483
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
483
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Irritable Bowel Syndrome I: Introduction
251
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
251
Anatomy of the Intestines
71.4K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
71.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K

